Keyword: Icahn School of Medicine at Mount Sinai
Mount Sinai researchers showed that in male mouse models of heart attack, Cdx2 placental cells regenerated damaged tissue.
Two months of treatment with the diabetes drug Jardiance reduced pulmonary congestion and biomarkers of heart failure in pig models.
Injecting a vaccine into tumor sites produced remissions in mice and some lymphoma patients in a study at Mount Sinai.
Researchers at Mount Sinai and IBM found a link between responses to some cancer treatments and mitochondria, the energy centers in cells.
Scientists from CUNY and the Icahn School of Medicine have identified a possible mechanism of action for Biogen's MS drug Tecfidera.
New biotech discoveries include CRISPR-induced conception and a biomarker for predicting breast cancer recurrences.
Researchers used the gene editing system CRISPR-Cas9 to discover a signature of resistance to BRAF inhibitors in melanoma.
After reprogramming a type of retinal cells, Mount Sinai scientists helped blind mice regain some visual function.
The past week’s biotech news included insight into how ApoE4 raises Alzheimer’s risk and a peptide vaccine for broad flu protection.
A "multi-omic" analysis of more than 900 donor brains linked the amount of herpes virus in a person's brain to the presence of Alzheimer's markers.